Sugi Predict

Sugi Predict / Compounds / SCHEMBL1443562

SCHEMBL1443562

SCHEMBL1443562

CCCCCCCCCCCCCCCCC(CC)C(=O)N(CC)CCN

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 7/20 0.43
▸ CA1 P00915 4/20 0.43
▸ GRIK1 P39086 2/20 0.41
▸ GRIK2 Q13002 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SLC1A2 P43004 1/20 0.38
▸ SLC1A1 P43005 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ PLA2G2A P14555 1/20 0.38
▸ GNAI3 P08754 1/20 0.37
▸ GNAO1 P09471 1/20 0.37
▸ GNAI1 P63096 1/20 0.37
▸ GPR84 Q9NQS5 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8891862 0.92 SLC6A5 (0.43) —
Lactic Acid SCHEMBL4855948 0.92 CA2 (0.41) CA2CA1GRIK1GRIK2MAPK1
Propylamine SCHEMBL7723165 0.90 CA2 (0.46) CA2CA1GRIK1GRIK2MAPK1
SCHEMBL29144960 0.87 CA2 (0.48) CA2CA1GRIK1GRIK2MAPK1
SCHEMBL27494955 0.85 CA2 (0.48) CA2CA1GRIK1GRIK2MAPK1
SCHEMBL8394136 0.82 CA2 (0.44) CA2CA1GRIK1GRIK2SLC1A2
SCHEMBL8397773 0.82 CA2 (0.44) CA2CA1GRIK1GRIK2SLC1A2
SCHEMBL8398322 0.82 CA2 (0.44) CA2CA1GRIK1GRIK2SLC1A2
SCHEMBL8396450 0.82 CA2 (0.44) CA2CA1GRIK1GRIK2SLC1A2
SCHEMBL8398002 0.82 CA2 (0.44) CA2CA1GRIK1GRIK2SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070256987-A1 Chemically-enhanced mechanical treatment of water AQUALON COMPANY 2007-11-08 — — US claimed
WO-2007075681-A1 CHEMICALLY-ENHANCED MECHANICAL TREATMENT OF WATER HERCULES INCORPORATED (US) 2007-07-05 — — WO claimed
US-6897281-B2 Breathable polyurethanes, blends, and articles NOVEON IP HOLDINGS CORP. (US) 2005-05-24 — — US claimed
EP-1392232-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME l'Oreal SA (FR) 2004-03-03 — — EP claimed
EP-1339374-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME l'Oreal SA (FR) 2003-09-03 — — EP claimed
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same L'OREAL S.A. (FR) 2003-05-01 — — US claimed
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same PINZON CARLOS O (US) 2002-09-05 — — US claimed
WO-2002047620-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 — — WO claimed
WO-2002047658-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 — — WO claimed
US-20250189415-A1 INKJET DEPOSITION OF REAGENTS FOR HISTOLOGICAL SAMPLES VENTANA MED SYST INC (US) 2025-06-12 — — US disclosed
US-20250146055-A1 HYBRIDIZATION BUFFER FORMULATIONS Roche Sequencing Solutions, Inc. 2025-05-08 — — US disclosed
US-12265003-B2 Inkjet deposition of reagents for histological samples VENTANA MEDICAL SYSTEMS, INC. (US) 2025-04-01 — — US disclosed
CN-118475675-A Compositions and methods 因诺斯佩克活性化学物有限责任公司 2024-08-09 — — CN disclosed
US-12053527-B2 Compositions with permeation enhancers for drug delivery CHILDREN'S MEDICAL CENTER CORPORATION (US) 2024-08-06 — — US disclosed
EP-0370764-A2 Hair care compositions THE PROCTER & GAMBLE COMPANY (US) 1990-05-30 — — EP disclosed
US-4906459-A Hair care compositions THE PROCTER & GAMBLE COMPANY (US) 1990-03-06 — — US disclosed
US-4902499-A Hair care compositions containing a rigid silicone polymer THE PROCTER & GAMBLE COMPANY (US) 1990-02-20 — — US disclosed
EP-0313307-A1 Hair care compositions THE PROCTER & GAMBLE COMPANY (US) 1989-04-26 — — EP disclosed
EP-0240350-A2 Hair care compositions THE PROCTER & GAMBLE COMPANY (US) 1987-10-07 — — EP disclosed
EP-0155806-A2 Hair conditioning compositions THE PROCTER & GAMBLE COMPANY (US) 1985-09-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS CA2 2974/4885CA1 4515/4885GRIK1 547/4885
US-12053527-B2 Compositions with permeation enhancers for drug delivery ABCB11, MMP1, SLC47A1 CA2 392/4885CA1 615/4885GRIK1 2066/4885
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS CA2 2974/4885CA1 4515/4885GRIK1 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.